Kao-Ping Chua1, Chad M Brummett2,3, Rena M Conti4, Amy S Bohnert2,5. 1. Division of General Pediatrics, Department of Pediatrics, Susan B. Meister Child Health Evaluation and Research Center, University of Michigan, Ann Arbor, Michigan chuak@med.umich.edu. 2. Division of Pain Medicine, Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan. 3. Michigan Opioid Prescribing Engagement Network, Ann Arbor, Michigan. 4. Department of Markets, Public Policy, And Law, Institute for Health System Innovation and Policy, Questrom School of Business, Boston University, Boston, Massachusetts. 5. VA Center for Clinical Management Research, VA Ann Arbor Health System, Ann Arbor.
Abstract
BACKGROUND: Recent national data are lacking on the prevalence, safety, and prescribers of opioid prescriptions dispensed to children and young adults aged 0 to 21 years. METHODS: We identified opioid prescriptions dispensed to children and young adults in 2019 in the IQVIA Longitudinal Prescription Database, which captures 92% of US pharmacies. We calculated the proportion of all US children and young adults with ≥1 dispensed opioid prescription in 2019. We calculated performance on 6 metrics of high-risk prescribing and the proportion of prescriptions written by each specialty. Of all prescriptions and those classified as high risk by ≥1 metric, we calculated the proportion written by high-volume prescribers with prescription counts at the ≥95th percentile. RESULTS: Analyses included 4 027 701 prescriptions. In 2019, 3.5% of US children and young adults had ≥1 dispensed opioid prescription. Of prescriptions for opioid-naive patients, 41.8% and 3.8% exceeded a 3-day and 7-day supply, respectively. Of prescriptions for young children, 8.4% and 7.7% were for codeine and tramadol. Of prescriptions for adolescents and young adults, 11.5% had daily dosages of ≥50 morphine milligram equivalents; 4.6% had benzodiazepine overlap. Overall, 45.6% of prescriptions were high risk by ≥1 metric. Dentists and surgeons wrote 61.4% of prescriptions. High-volume prescribers wrote 53.3% of prescriptions and 53.1% of high-risk prescriptions. CONCLUSIONS: Almost half of pediatric opioid prescriptions are high risk. To reduce high-risk prescribing, initiatives targeting high-volume prescribers may be warranted. However, broad-based initiatives are also needed to address the large share of high-risk prescribing attributable to other prescribers.
BACKGROUND: Recent national data are lacking on the prevalence, safety, and prescribers of opioid prescriptions dispensed to children and young adults aged 0 to 21 years. METHODS: We identified opioid prescriptions dispensed to children and young adults in 2019 in the IQVIA Longitudinal Prescription Database, which captures 92% of US pharmacies. We calculated the proportion of all US children and young adults with ≥1 dispensed opioid prescription in 2019. We calculated performance on 6 metrics of high-risk prescribing and the proportion of prescriptions written by each specialty. Of all prescriptions and those classified as high risk by ≥1 metric, we calculated the proportion written by high-volume prescribers with prescription counts at the ≥95th percentile. RESULTS: Analyses included 4 027 701 prescriptions. In 2019, 3.5% of US children and young adults had ≥1 dispensed opioid prescription. Of prescriptions for opioid-naive patients, 41.8% and 3.8% exceeded a 3-day and 7-day supply, respectively. Of prescriptions for young children, 8.4% and 7.7% were for codeine and tramadol. Of prescriptions for adolescents and young adults, 11.5% had daily dosages of ≥50 morphine milligram equivalents; 4.6% had benzodiazepine overlap. Overall, 45.6% of prescriptions were high risk by ≥1 metric. Dentists and surgeons wrote 61.4% of prescriptions. High-volume prescribers wrote 53.3% of prescriptions and 53.1% of high-risk prescriptions. CONCLUSIONS: Almost half of pediatric opioid prescriptions are high risk. To reduce high-risk prescribing, initiatives targeting high-volume prescribers may be warranted. However, broad-based initiatives are also needed to address the large share of high-risk prescribing attributable to other prescribers.
Authors: Mollie R Freedman-Weiss; Alexander S Chiu; David Worhunsky; Alefteria Manchisi; Isabel Torres-Maldonado; Lisa Sagnella; Michael G Caty; Robert A Cowles; Doruk E Ozgediz; Emily R Christison-Lagay; Daniel G Solomon; David H Stitelman Journal: J Pediatr Surg Date: 2019-10-26 Impact factor: 2.545
Authors: Calista M Harbaugh; Gracia Vargas; Courtney Shepard Streur; G Ying Li; Aaron L Thatcher; Jennifer F Waljee; Samir K Gadepalli Journal: JAMA Surg Date: 2019-12-01 Impact factor: 14.766
Authors: Kelby W Brown; Kayla Carlisle; Sudha R Raman; Peter Shrader; Megan Jiao; Michael J Smith; Lisa M Einhorn; Charlene A Wong Journal: Health Aff (Millwood) Date: 2020-10 Impact factor: 6.301
Authors: Kao-Ping Chua; Hsou-Mei Hu; Jennifer F Waljee; Chad M Brummett; Romesh P Nalliah Journal: J Am Dent Assoc Date: 2021-02-23 Impact factor: 3.634
Authors: Gery P Guy; Andrea E Strahan; Tamara Haegerich; Jan L Losby; Kathleen Ragan; Mary E Evans; Christopher M Jones Journal: J Gen Intern Med Date: 2021-03-09 Impact factor: 6.473
Authors: Romesh P Nalliah; Kenneth R Sloss; Brooke C Kenney; Sarah K Bettag; Shernel Thomas; Kendall Dubois; Jennifer F Waljee; Chad M Brummett Journal: JAMA Netw Open Date: 2020-03-02
Authors: Sean Esteban McCabe; Carol J Boyd; Rebecca J Evans-Polce; Vita V McCabe; John E Schulenberg; Philip T Veliz Journal: J Addict Med Date: 2021 May-Jun 01 Impact factor: 4.647
Authors: Lorraine I Kelley-Quon; Matthew G Kirkpatrick; Robert L Ricca; Robert Baird; Calista M Harbaugh; Ashley Brady; Paula Garrett; Hale Wills; Jonathan Argo; Karen A Diefenbach; Marion C W Henry; Juan E Sola; Elaa M Mahdi; Adam B Goldin; Shawn D St Peter; Cynthia D Downard; Kenneth S Azarow; Tracy Shields; Eugene Kim Journal: JAMA Surg Date: 2021-01-01 Impact factor: 14.766
Authors: Kao-Ping Chua; Jennifer F Waljee; Vidhya Gunaseelan; Romesh P Nalliah; Chad M Brummett Journal: Am J Prev Med Date: 2022-03 Impact factor: 5.043
Authors: Molly Moore Jeffery; Mitra Ahadpour; Summer Allen; Richardae Araojo; Fernanda Bellolio; Nancy Chang; Laura Ciaccio; Lindsay Emanuel; Jonathan Fillmore; Gregg H Gilbert; Patricia Koussis; Christine Lee; Heather Lipkind; Celeste Mallama; Tamra Meyer; Megan Moncur; Teryl Nuckols; Michael A Pacanowski; David B Page; Elektra Papadopoulos; Jessica D Ritchie; Joseph S Ross; Nilay D Shah; Mat Soukup; Christopher O St Clair; Stephen Tamang; Sam Torbati; Douglas W Wallace; Yueqin Zhao; Rebekah Heckmann Journal: BMJ Open Date: 2022-07-05 Impact factor: 3.006
Authors: Adam C Adler; Brittany E Bryant; David Baszynski; Andrew Lee; Eduardo Medellin; Jennifer McCarthy; Andrea White; Brian H Nathanson; Arvind Chandrakantan Journal: Paediatr Anaesth Date: 2022-05-01 Impact factor: 2.129
Authors: Elizabeth M Stone; Kayla N Tormohlen; Alexander D McCourt; Ian Schmid; Elizabeth A Stuart; Corey S Davis; Mark C Bicket; Emma E McGinty Journal: JAMA Health Forum Date: 2022-08-05